Form 8-K - Current report:
SEC Accession No. 0001140361-21-040536
Filing Date
2021-12-07
Accepted
2021-12-07 06:02:45
Documents
14
Period of Report
2021-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10031559_8k.htm   iXBRL 8-K 24290
2 EXHIBIT 99.1 brhc10031559_ex99-1.htm EX-99.1 23833
6 image00001.jpg GRAPHIC 4658
  Complete submission text file 0001140361-21-040536.txt   196524

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20211206.xsd EX-101.SCH 3932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20211206_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20211206_pre.xml EX-101.PRE 16048
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10031559_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 211474607
SIC: 2834 Pharmaceutical Preparations